Variant report
Variant | nsv969350 |
---|---|
Chromosome Location | chr6:13517777-13522974 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:36)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:36 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr6:13517443-13517812 | HepG2 | liver: | n/a | n/a |
2 | BCL3 | chr6:13518956-13519406 | GM12878 | blood: | n/a | n/a |
3 | CEBPB | chr6:13517345-13517893 | MCF-7 | breast: | n/a | chr6:13517619-13517630 |
4 | CEBPB | chr6:13517441-13517804 | HepG2 | liver: | n/a | chr6:13517619-13517630 |
5 | E2F4 | chr6:13522934-13523274 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | EP300 | chr6:13522806-13523381 | SK-N-SH | brain: | n/a | chr6:13523150-13523164 |
7 | FOS | chr6:13521832-13522033 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOS | chr6:13522870-13523295 | MCF10A-Er-Src | breast: | n/a | chr6:13523087-13523095 chr6:13523087-13523094 |
9 | FOS | chr6:13522900-13523229 | MCF10A-Er-Src | breast: | n/a | chr6:13523087-13523095 chr6:13523087-13523094 |
10 | FOS | chr6:13522792-13523280 | MCF10A-Er-Src | breast: | n/a | chr6:13523087-13523095 chr6:13523087-13523094 |
11 | FOS | chr6:13521893-13521975 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr6:13522429-13523298 | HUVEC | blood vessel: | n/a | chr6:13523087-13523095 chr6:13523087-13523094 |
13 | FOS | chr6:13522793-13523288 | MCF10A-Er-Src | breast: | n/a | chr6:13523087-13523095 chr6:13523087-13523094 |
14 | FOSL2 | chr6:13522729-13523377 | SK-N-SH | brain: | n/a | chr6:13523087-13523095 chr6:13523087-13523094 |
15 | GATA2 | chr6:13522815-13523383 | HUVEC | blood vessel: | n/a | n/a |
16 | GATA3 | chr6:13522781-13523363 | SK-N-SH | brain: | n/a | n/a |
17 | GATA3 | chr6:13517072-13517933 | MCF-7 | breast: | n/a | n/a |
18 | GATA3 | chr6:13522711-13523398 | SK-N-SH | brain: | n/a | n/a |
19 | GATA3 | chr6:13517157-13517901 | MCF-7 | breast: | n/a | n/a |
20 | JUN | chr6:13521881-13522008 | HepG2 | liver: | n/a | n/a |
21 | JUN | chr6:13520334-13520459 | HepG2 | liver: | n/a | chr6:13520348-13520361 |
22 | JUN | chr6:13522823-13523276 | HUVEC | blood vessel: | n/a | chr6:13523087-13523095 chr6:13523087-13523094 |
23 | JUND | chr6:13522824-13523327 | SK-N-SH | brain: | n/a | chr6:13523087-13523095 chr6:13523087-13523094 |
24 | JUND | chr6:13521804-13522004 | HepG2 | liver: | n/a | chr6:13521908-13521919 |
25 | NR2F2 | chr6:13517276-13517824 | MCF-7 | breast: | n/a | n/a |
26 | PBX3 | chr6:13522724-13523339 | SK-N-SH | brain: | n/a | n/a |
27 | PBX3 | chr6:13517272-13517848 | SK-N-SH | brain: | n/a | n/a |
28 | PBX3 | chr6:13522847-13523329 | SK-N-SH | brain: | n/a | n/a |
29 | POLR2A | chr6:13522755-13523267 | SK-N-MC | brain: | n/a | n/a |
30 | POLR2A | chr6:13522719-13523230 | HUVEC | blood vessel: | n/a | n/a |
31 | STAT3 | chr6:13522809-13523255 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | STAT3 | chr6:13519541-13519585 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | STAT3 | chr6:13522841-13523277 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | STAT3 | chr6:13522883-13523243 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | STAT3 | chr6:13522898-13523243 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | TCF12 | chr6:13522699-13523397 | SK-N-SH | brain: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPS4XP7 | TF binding region |
ENSG00000187461 | chromatin interactions |
ENSG00000145990 | chromatin interactions |
ENSG00000237786 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138299836 | chr6:13517788-13517789 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs199600986 | chr6:13517793-13517794 | Weak transcription Enhancers Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs562609192 | chr6:13517847-13517848 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs192949184 | chr6:13517885-13517886 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs9474387 | chr6:13517912-13517913 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs144281029 | chr6:13517974-13517975 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs532089165 | chr6:13518056-13518057 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs562668717 | chr6:13518067-13518068 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs531518827 | chr6:13518082-13518083 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs115862948 | chr6:13518125-13518126 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs72826990 | chr6:13518131-13518132 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs368283389 | chr6:13518152-13518153 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs548895909 | chr6:13518153-13518154 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs143215389 | chr6:13518159-13518160 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs147500551 | chr6:13518161-13518162 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs59696155 | chr6:13518174-13518175 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs570818682 | chr6:13518190-13518191 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs185148800 | chr6:13518192-13518193 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs553499844 | chr6:13518213-13518214 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs189368248 | chr6:13518289-13518290 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs62385844 | chr6:13518318-13518319 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs200501370 | chr6:13518320-13518321 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs554722187 | chr6:13518340-13518341 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs376341051 | chr6:13518360-13518361 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs564228085 | chr6:13518395-13518396 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs150940710 | chr6:13518422-13518423 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs562988342 | chr6:13518423-13518424 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs113666417 | chr6:13518453-13518454 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs10948735 | chr6:13518499-13518500 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs73372879 | chr6:13518529-13518530 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs528151813 | chr6:13518553-13518554 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs368783464 | chr6:13518584-13518585 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs373177311 | chr6:13518644-13518645 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs548517222 | chr6:13518645-13518646 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs568590623 | chr6:13518675-13518676 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs4715379 | chr6:13518729-13518730 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs149705827 | chr6:13518732-13518733 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs113891646 | chr6:13518736-13518737 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs569427575 | chr6:13518743-13518744 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs181735264 | chr6:13518767-13518768 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs76835409 | chr6:13518769-13518770 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs539465330 | chr6:13518780-13518781 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs186254743 | chr6:13518788-13518789 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs4715380 | chr6:13518789-13518790 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs113935796 | chr6:13518869-13518870 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs574569194 | chr6:13518888-13518889 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs543362534 | chr6:13518921-13518922 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs12204301 | chr6:13518929-13518930 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs201810722 | chr6:13518945-13518946 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs149118700 | chr6:13518961-13518962 | Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 16790693 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:13513000-13527200 | Weak transcription | Right Atrium | heart |
2 | chr6:13514400-13524400 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
3 | chr6:13516800-13517800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr6:13517000-13517800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr6:13517000-13517800 | Enhancers | HUVEC | blood vessel |
6 | chr6:13517000-13518000 | Enhancers | NHEK | skin |
7 | chr6:13517200-13517800 | Bivalent Enhancer | HepG2 | liver |
8 | chr6:13517200-13517800 | Enhancers | HMEC | breast |
9 | chr6:13517200-13524000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr6:13517400-13518000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr6:13517800-13521600 | Weak transcription | HUVEC | blood vessel |
12 | chr6:13517800-13524000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr6:13518000-13521600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr6:13519200-13519400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr6:13519400-13523200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr6:13521600-13523400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr6:13521600-13523400 | Enhancers | NHEK | skin |
18 | chr6:13521600-13529200 | Enhancers | HUVEC | blood vessel |
19 | chr6:13521800-13522200 | Enhancers | Spleen | Spleen |
20 | chr6:13522200-13524000 | Weak transcription | Spleen | Spleen |
21 | chr6:13522200-13524400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
22 | chr6:13522600-13522800 | Enhancers | Fetal Brain Male | brain |
23 | chr6:13522600-13523400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
24 | chr6:13522800-13523400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
25 | chr6:13522800-13523400 | Enhancers | Osteobl | bone |
26 | chr6:13522800-13525000 | Weak transcription | Fetal Brain Male | brain |
27 | chr6:13522800-13527200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |